Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 35
- Next page
Title | Authors | Year | Journal Sort descending | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia | Shrestha S, Nazy I, Smith JW, Kelton JG, Arnold DM | 2020 | Blood Adv | View Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia | Health care providers | Clinical research |
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Liem RI, Lanzkron S, T DC, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA | 2019 | Blood Adv | View American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Health care providers | Benchmarking and standard setting |
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Cuker A AG, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N | 2018 | Blood Adv | View American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Health care providers | Benchmarking and standard setting |
Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses | Morgan RL, Ashoorion V, Cuker A, Begum H, Ross S, Martinez N, Chong BH, Linkins LA, Warkentin TE, Wiercioch W, Nieuwlaat R, Schünemann H, Santesso N | 2020 | Blood Adv | View Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses | Researchers | Clinical research |
A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Jiang D, Lim W, Crowther M, Garcia D | 2021 | Blood Adv | View A systematic review of the association between anti-?-2 glycoprotein I antibodies and APS manifestations | Researchers | Clinical research |
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Giles JB, Steiner HE, Rollin J, Shaffer CM, Momozawa Y, Mushiroda T, Inai C, Selleng K, Thiele T, Pouplard C, Heddle NM, Kubo M, Miller EC, Martinez KL, Phillips EJ, Warkentin TE, Gruel Y, Greinacher A, Roden DM, Karnes JH | 2022 | Blood Adv | View Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia | Researchers | Basic research |
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, E AA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ | 2021 | Blood Adv | View American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 | Health care providers | Benchmarking and standard setting |
A user guide to the American Society of Hematology clinical practice guidelines | Izcovich A, Cuker A, Kunkle R, Neumann I, Panepinto J, Pai M, Seftel M, Cheung MC, Lottenberg R, Byrne M, Plovnick R, Terrell D, Holter-Chakrabarty JL, Djulbegovic B, Hicks LK, Wiercioch W, Nieuwlaat R, Schünemann HJ | 2020 | Blood Adv | View A user guide to the American Society of Hematology clinical practice guidelines | Health care providers | Benchmarking and standard setting |
Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets | Zufferey A, Speck ER, Machlus KR, Aslam R, Guo L, McVey MJ, Kim M, Kapur R, Boilard E, Italiano JE, Jr., Semple JW | 2017 | Blood Adv | View Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets | Researchers | Basic research |
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Huynh A, Arnold DM, Michael JV, Clare R, Smith JW, Daka M, Ianosi-Irimie M, McKenzie SE, Kelton JG, Nazy I | 2023 | Blood Adv | View Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S | Researchers | Clinical research |
Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Alshalani A, Uhel F, Cremer OL, Schultz MJ, de Vooght KMK, van Bruggen R, Acker JP, Juffermans NP, on behalf of the MARS Consortium | 2022 | Blood Adv | View Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Researchers | Clinical research |
Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Alshalani A, Uhel F, Cremer OL, Schultz MJ, de Vooght KMK, van Bruggen R, Acker JP, Juffermans NP | 2022 | Blood Adv | View Donor-recipient sex is associated with transfusion-related outcomes in critically ill patients | Researchers | Clinical research |
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia | Appelbaum J, Arnold DM, Kelton JG, Gernsheimer T, Jevtic SD, Ivetic N, Smith JW, Nazy I | 2022 | Blood Adv | View SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia | Researchers | Basic research |
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Kjeldsen-Kragh J, Fergusson DA, Kjaer M, Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia HF, Landry D, Shehata N | 2020 | Blood Adv | View Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Health care providers | Clinical research |
Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F | 2022 | Blood Adv | View Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia | Health care providers | Clinical research |
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Darzi AJ, Repp AB, Spencer FA, Morsi RZ, Charide R, Etxeandia-Ikobaltzeta I, Bauer KA, Burnett AE, Cushman M, Dentali F, Kahn SR, Rezende SM, Zakai NA, Agarwal A, Karam SG, Lotfi T, Wiercioch W, Waziry R, Iorio A, Akl EA, Schünemann HJ | 2020 | Blood Adv | View Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Health care providers | Clinical research |
Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry | Arnold DM, Nazy I, Clare R, Jaffer AM, Aubie B, Li N, Kelton JG | 2017 | Blood Adv | View Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry | Health care providers | Clinical research |
Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Almizraq RJ, Norris PJ, Inglis H, Menocha S, Wirtz MR, Juffermans N, Pandey S, Spinella PC, Acker JP, Muszynski JA | 2018 | Blood Adv | View Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Researchers | Basic research |
Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion | Ebraheem MS, Verhovsek M | 2021 | Blood Adv | View Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion | Health care providers | Clinical research |
MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity | Saha MN, Jiang H, Jayakar J, Reece D, Branch DR, Chang H | 2010 | Cancer Biol Ther | View MDM2 antagonist nutlin plus proteasome inhibitor velcade combination displays a synergistic anti-myeloma activity | Researchers | Basic research |
Mechanism of hemoglobin-induced cellular injury in desiccated red blood cells | Kanias T, Acker JP | 2010 | Free Radic Biol Med | View Mechanism of hemoglobin-induced cellular injury in desiccated red blood cells | Researchers | Basic research |
Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-? | Marquez-Curtis LA, Shirvaikar N, Turner AR, Mirza I, Surmawala A, Larratt LM, Janowska-Wieczorek A | 2012 | Cancers | View Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-? | Researchers | Basic research |
Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study | Chornenki NLJ, Siegal DM, Qamar K, Woolgar S, Rangarajan S, Karampatos S, Leong DP, Hillis CM | 2022 | Leuk Res | View Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study | Researchers | Clinical research |
Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors | Chandran P, Le Y, Li Y, Sabloff M, Mehic J, Rosu-Myles M, Allan DS | 2015 | Leuk Res | View Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors | Researchers | Basic research |
Microfluidic deformability analysis of the red cell storage lesion | Matthews K, Myrand-Lapierre M-E, Ang RR, Duffy SP, Scott MD, Ma H | 2015 | J Biomech | View Microfluidic deformability analysis of the red cell storage lesion | Researchers | New or improved product or process |
Microfluidic analysis of red blood cell deformability | Guo Q, Duffy SP, Matthews K, Santoso AT, Scott MD, Ma H | 2014 | J Biomech | View Microfluidic analysis of red blood cell deformability | Researchers | Basic research |
Microfluidic analysis of red blood cell deformability as a means to assess hemin-induced oxidative stress resulting from Plasmodium falciparum intraerythrocytic parasitism | Matthews K, Duffy SP, Myrand-Lapierre M-E, Ang RR, Li L, Scott MD, Ma H | 2017 | Integr Biol | View Microfluidic analysis of red blood cell deformability as a means to assess hemin-induced oxidative stress resulting from Plasmodium falciparum intraerythrocytic parasitism | Researchers | Basic research |
Microfluidic determination of lymphocyte vascular deformability: effects of intracellular complexity and early immune activation | Kang N, Guo Q, Islamzada E, Ma H, Scott MD | 2018 | Integr Biol | View Microfluidic determination of lymphocyte vascular deformability: effects of intracellular complexity and early immune activation | Researchers | Basic research |
Microfluidic approach to genotyping human platelet antigens | Lim C, Manage DP, Atrazhev A, Denomme G, Backhouse CJ, Acker JP | 2012 | IET Nanobiotechnol | View Microfluidic approach to genotyping human platelet antigens | Researchers | New or improved product or process |
Microscope-based label-free microfluidic cytometry | Su X, Kirkwood SE, Gupta M, Marquez-Curtis L, Qiu Y, Janowska-Wieczorek A, Rozmus W, Tsui YY | 2011 | Opt Express | View Microscope-based label-free microfluidic cytometry | Researchers | New or improved product or process |
Migration, proliferation and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic acid | Marquez-Curtis LA, Qiu Y, Xu A, Janowska-Wieczorek A | 2014 | Stem Cells Int | View Migration, proliferation and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic acid | Researchers | Basic research |
Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study | van Schalkwyk J, Nourmoussavi M, Massey A, Gustafson R, Brodkin E, Petric M, Krajden M, Dobson S, Buxton J, Bigham M, Pick N, Schreiber R, Sherlock CH, Money D, Yoshida EM | 2014 | Can J Gastroenterol Hepatol | View Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study | Health care providers | Clinical research |
Mitochondrial Inner Membrane Depolarization as a Marker of Platelet Apoptosis: Disclosure of Nonapoptotic Membrane Depolarization | Gyulkhandanyan AV, Allen DJ, Mykhaylov S, Lyubimov E, Ni H, Freedman J, Leytin V | 2016 | Clin Appl Thromb Hemost | View Mitochondrial Inner Membrane Depolarization as a Marker of Platelet Apoptosis: Disclosure of Nonapoptotic Membrane Depolarization | Researchers | Basic research |
Modeling of body weight metrics for effective and cost-efficient conventional factor VIII dosing in hemophilia A prophylaxis | McEneny-King A, Chelle P, Henrard S, Hermans C, Iorio A, Edginton AN | 2017 | Pharmaceutics | View Modeling of body weight metrics for effective and cost-efficient conventional factor VIII dosing in hemophilia A prophylaxis | Health care providers | Clinical research |
Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression | Bhullar KS, Nael MA, Elokely KM, Drews SJ, Wu J | 2022 | Pharmaceutics | View Structurally Modified Bioactive Peptide Inhibits SARS-CoV-2 Lentiviral Particles Expression | Researchers | Basic research |
Modeling the optimal ethnic composition of an adult stem cell registry | Blake JT, McTaggart K, Killeen D | 2018 | Eur J Oper Res | View Modeling the optimal ethnic composition of an adult stem cell registry | Blood operators | New or improved product or process |
Modulation of microRNA Activity by Semi-microRNAs | Plante I, Ple H, Landry P, Gunaratne PH, Provost P | 2012 | Front Genet | View Modulation of microRNA Activity by Semi-microRNAs | Researchers | Basic research |
The Virulence of S. marcescens Strains Isolated From Contaminated Blood Products Is Divergent in the C. elegans Infection Model | Diamandas A, Razon MR, Ramirez-Arcos S, Brassinga AKC | 2021 | Front Genet | View The Virulence of S. marcescens Strains Isolated From Contaminated Blood Products Is Divergent in the C. elegans Infection Model | Researchers | Basic research |
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015 | Flegel WA, Castilho L, Heaton WA, Keller MA, Klapper EB, Lane WJ, Pirenne F, Shehata N, Stack G, St-Louis M, Tormey CA, Wagner FF, Waxman DA, Denomme GA | 2016 | Transfusion | View Molecular immunohaematology round table discussions at the AABB Annual Meeting, Anaheim 2015 | Health care providers | Clinical research |
Monoclonal versus polyclonal anti-D in the treatment of ITP | Lazarus AH | 2013 | Expert Opin Biol Ther | View Monoclonal versus polyclonal anti-D in the treatment of ITP | Researchers | Basic research |
Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells | Raj M, Langley M, McArthur SJ, Jean F | 2017 | J Gen Virol | View Moonlighting glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is required for efficient hepatitis C virus and dengue virus infections in human Huh-7.5.1 cells | Researchers | Basic research |
Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP) | Neschadim A, Branch DR | 2016 | Curr Protoc Immunol | View Mouse Models for Immune-Mediated Platelet Destruction or Immune Thrombocytopenia (ITP) | Researchers | Basic research |
Mouse Models of Autoimmune Diseases: Immune Thrombocytopenia | Neschadim A, Branch DR | 2015 | Current Pharmaceutical Design | View Mouse Models of Autoimmune Diseases: Immune Thrombocytopenia | Researchers | Basic research |
Tantalum-containing mesoporous bioactive glass powder for hemostasis | Nagrath M, Gallant R, Yazdi AR, Mendonca A, Rahman S, Chiu L, Waldman SD, Ni H, Towler MR | 2021 | J Biomater Appl | View Tantalum-containing mesoporous bioactive glass powder for hemostasis | Researchers | Basic research |
Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect | Gu W, Chen J, Patra P, Yang X, Gu Q, Wei L, Acker J, Kong B | 2017 | J Biomater Appl | View Nanoformulated water-soluble paclitaxel to enhance drug efficacy and reduce hemolysis side effect | Researchers | Basic research |
Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit | Bhatia K, Solanki S, Paes B, Chan AKC, Bhatt MD | 2022 | Pediatr Blood Cancer | View Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit | Researchers | Clinical research |
Platelet transfusion practice and platelet refractoriness for a cohort of pediatric oncology patients: A single-center study | Lieberman L, Liu Y, Barty R, Heddle NM | 2020 | Pediatr Blood Cancer | View Platelet transfusion practice and platelet refractoriness for a cohort of pediatric oncology patients: A single-center study | Health care providers | Clinical research |
Positioning new treatments in the management of immune thrombocytopenia | Arnold DM | 2013 | Pediatr Blood Cancer | View Positioning new treatments in the management of immune thrombocytopenia | Researchers | Clinical research |
Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Lieberman L, Lin Y, Cserti-Gazdewich C, Yi QL, Pendergrast J, Lau W, Callum J | 2018 | Pediatr Blood Cancer | View Utilization of frozen plasma, cryoprecipitate, and recombinant factor VIIa for children with hemostatic impairments: An audit of transfusion appropriateness | Health care providers | Clinical research |
Pharmacy hydroxyurea education materials for patients with sickle cell disease: An environmental scan and assessment of accuracy | Cervi A, Diamantouros A, Azzam M, Lane SJ, Sapru H, Verhovsek M | 2020 | Pediatr Blood Cancer | View Pharmacy hydroxyurea education materials for patients with sickle cell disease: An environmental scan and assessment of accuracy | Researchers | Benchmarking and standard setting |